|
MechanismHSPA1A modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseSuspended |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismHSP90 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Synta, Inc.
0 Patents (Medical) associated with Synta, Inc.
100 Deals associated with Synta, Inc.
100 Translational Medicine associated with Synta, Inc.